Department of Surgery and Cancer, Imperial College London, London, UK.
Ann Surg Oncol. 2012 Jun;19(6):1759-65. doi: 10.1245/s10434-011-2187-0. Epub 2011 Dec 30.
The quality of decision-making in cancer multidisciplinary team (MDT) meetings is variable, which can result in suboptimal clinical decision making. We developed MDT-QuIC, an evidence-based tool to support clinical decision making by MDTs, which was evaluated by key users.
Following a literature review, factors important for high-quality clinical decision making were listed and then converted into a preliminary checklist by clinical and safety experts. Attitudes of MDT members toward the tool were evaluated via an online survey, before adjustments were made giving rise to a final version: MDT-QuIC.
The checklist was evaluated by 175 MDT members (surgeons = 38, oncologists = 40, specialist nurses = 62, and MDT coordinators = 35). Attitudes toward the checklist were generally positive (P < 0.001, 1-sample t test), although nurses were more positive than other groups regarding whether the checklist would improve their contribution in MDT meetings (P < 0.001, Mann-Whitney U test). Participants thought that the checklist could be used to prepare cases for MDT meetings, to structure and guide case discussions, or as a record of MDT discussion. Regarding who could use the checklist, 70% thought it should be used by the MDT chair, 54% by the MDT coordinator, and 38% thought all MDT members should use it.
We have developed and validated an evidence-based tool to support the quality of MDT decision making. MDT members were positive about the checklist and felt it may help to structure discussion, improve inclusivity, and patient centeredness. Further research is needed to assess its effect on patient care and outcomes.
癌症多学科团队(MDT)会议的决策质量参差不齐,这可能导致临床决策不理想。我们开发了 MDT-QuIC,这是一种基于证据的工具,旨在通过 MDT 支持临床决策,该工具已由关键用户进行评估。
在文献回顾之后,列出了对高质量临床决策很重要的因素,然后由临床和安全专家将其转化为初步清单。通过在线调查评估 MDT 成员对该工具的态度,然后进行调整,最终形成一个版本:MDT-QuIC。
该清单由 175 名 MDT 成员(外科医生=38 名,肿瘤学家=40 名,专科护士=62 名,MDT 协调员=35 名)进行了评估。成员对清单的态度总体上是积极的(P<0.001,单样本 t 检验),尽管护士比其他群体更积极地认为清单将改善他们在 MDT 会议中的贡献(P<0.001,Mann-Whitney U 检验)。参与者认为清单可用于为 MDT 会议准备病例,为病例讨论提供结构和指导,或作为 MDT 讨论的记录。关于谁可以使用清单,70%的人认为应由 MDT 主席使用,54%的人认为应由 MDT 协调员使用,38%的人认为所有 MDT 成员都应该使用。
我们已经开发并验证了一种基于证据的工具,以支持 MDT 决策的质量。MDT 成员对清单持积极态度,并认为它可能有助于组织讨论,提高包容性和以患者为中心。需要进一步研究以评估其对患者护理和结果的影响。